folic acid and ag 2034
folic acid has been researched along with ag 2034 in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boritzki, TJ; Jackson, RC; Zhang, CC | 1 |
| Assaraf, YG; Bunni, M; Drori, S; Jansen, G; Kathmann, I; Mauritz, R; Noordhuis, P; Peters, GJ; Pinedo, HM; Priest, DG; Schornagel, JH; Sprecher, H | 1 |
| Faessel, HM; Greco, WR; Rustum, YM; Slocum, HK | 2 |
| Au, JL; Wientjes, MG; Zhao, L | 1 |
| Donev, AN | 1 |
| Bijnens, L; Straetemans, R | 1 |
| Kong, M; Lee, JJ | 1 |
| Kong, M; Lee, JJ; Lin, HY; Liu, DD | 1 |
| Peterson, JJ | 1 |
Reviews
1 review(s) available for folic acid and ag 2034
| Article | Year |
|---|---|
A review of synergy concepts of nonlinear blending and dose-reduction profiles.
Topics: Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Folic Acid; Glutamates; Models, Theoretical; Pyrimidines; Trimetrexate | 2010 |
Other Studies
9 other study(ies) available for folic acid and ag 2034
| Article | Year |
|---|---|
An inhibitor of glycinamide ribonucleotide formyltransferase is selectively cytotoxic to cells that lack a functional G1 checkpoint.
Topics: Animals; DNA, Neoplasm; Enzyme Inhibitors; Folic Acid; G1 Phase; Glutamates; HeLa Cells; Humans; Hydroxymethyl and Formyl Transferases; Mice; Phosphoribosylglycinamide Formyltransferase; Purines; Pyrimidines | 1998 |
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
Topics: Affinity Labels; Biological Transport; Blotting, Northern; Carrier Proteins; Drug Resistance, Neoplasm; Folic Acid; Folic Acid Antagonists; Glutamates; Humans; Kinetics; Leukemia; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Pyrimethamine; Pyrimidines; Reduced Folate Carrier Protein; Structure-Activity Relationship; Tetrahydrofolates; Trimetrexate; Tumor Cells, Cultured | 1998 |
Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin -6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Drug Resistance, Multiple; Drug Synergism; Folic Acid; Folic Acid Antagonists; Glutamates; Head and Neck Neoplasms; Humans; Hydroxymethyl and Formyl Transferases; Kinetics; Lung Neoplasms; Phosphoribosylglycinamide Formyltransferase; Pyrimidines; Trimetrexate; Tumor Cells, Cultured | 1999 |
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Cell Division; Drug Resistance, Multiple; Drug Synergism; Enzyme Inhibitors; Folic Acid; Glutamates; Hematinics; Humans; Hydroxymethyl and Formyl Transferases; Hypoxanthine; Ileal Neoplasms; Peptide Synthases; Phosphoribosylglycinamide Formyltransferase; Pyrimidines; Quinazolines; Thiophenes; Thymidine; Thymidylate Synthase; Trimetrexate; Tumor Cells, Cultured | 2003 |
Comparison of methods for evaluating drug-drug interaction.
Topics: Cell Line, Tumor; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Synergism; Folic Acid; Glutamates; Humans; Models, Theoretical; Pyrimidines; Trimetrexate | 2010 |
Comparison of methods for statistical analysis of combination studies.
Topics: Cell Line, Tumor; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Synergism; Folic Acid; Glutamates; Humans; Models, Theoretical; Pyrimidines; Trimetrexate | 2010 |
Application and review of the separate ray model to investigate interaction effects.
Topics: Cell Line, Tumor; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Folic Acid; Glutamates; Humans; Models, Theoretical; Pyrimidines; Research Design; Trimetrexate | 2010 |
Applying Emax model and bivariate thin plate splines to assess drug interactions.
Topics: Analysis of Variance; Cell Line, Tumor; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Folic Acid; Glutamates; Humans; Models, Theoretical; Pyrimidines; Trimetrexate | 2010 |
Emax model and interaction index for assessing drug interaction in combination studies.
Topics: Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Combinations; Drug Design; Drug Interactions; Folic Acid; Glutamates; Pyrimidines; Trimetrexate | 2010 |